sacituzumab
gilead sciences
['mbc', 'sacituzumab', 'bcsm']
sacituzumab improves os and orr compared to standard chemo in hr+/her2- mbc. more options for our patients! #bcsm #esmo22 await fda approval in this indication. 
Breast Medical Oncologist @dukecancer. Clinical investigator. Mom of ???. Tweet=own opinion not advice.